Metabolite Identification Data in Drug Discovery, Part 2: Site-of-Metabolism Annotation, Analysis, and Exploration for Machine Learning

The ability to pinpoint and predict sites of metabolism (SoMs) is essential for designing and optimizing effective and safe bioactive small molecules. However, the number of molecules with annotated SoMs is limited, hindering the advancement of data-driven methods such as machine learning for metabolism prediction. Here, we provide a comprehensive characterization of SoM data obtained from the readouts of a human hepatocyte assay conducted at AstraZeneca Gothenburg. We explore a new strategy for SoM annotation that accounts for uncertainty in the experimental data, and we relate our findings to the most comprehensive SoM data collection available to date. Our study includes entropy analysis of SoM annotations, accompanied by representative examples that highlight the complexities of interpreting and working with metabolism data. Furthermore, we demonstrate the impact and value of the new metabolism data on SoM prediction. Importantly, a substantial portion of the data generated and analyzed as part of this work is made publicly available.

Authors

Institutions

Publication Details

Journal
Molecular Pharmaceutics
Published
2025-10-21
DOI
https://doi.org/10.1021/acs.molpharmaceut.5c00740
Citations
1
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
1.50
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Metabolite Identification Data in Drug Discovery, Part 2: Site-of-Metabolism Annotation, Analysis, and Exploration for Machine Learning

Susanne Winiwarter, Angelica Mazzolari, R. Jacob, Marie Ahlqvist et al.
1 citations
Molecular Pharmaceutics
Computational Drug Discovery Methods
1.50
article

Metabolite Identification Data in Drug Discovery, Part 2: Site-of-Metabolism Annotation, Analysis, and Exploration for Machine Learning

Susanne Winiwarter, Angelica Mazzolari, R. Jacob, Marie Ahlqvist, Ya Chen, Johannes Kirchmair, Filip Miljković
article en
1 citations

Abstract

The ability to pinpoint and predict sites of metabolism (SoMs) is essential for designing and optimizing effective and safe bioactive small molecules. However, the number of molecules with annotated SoMs is limited, hindering the advancement of data-driven methods such as machine learning for metabolism prediction. Here, we provide a comprehensive characterization of SoM data obtained from the readouts of a human hepatocyte assay conducted at AstraZeneca Gothenburg. We explore a new strategy for SoM annotation that accounts for uncertainty in the experimental data, and we relate our findings to the most comprehensive SoM data collection available to date. Our study includes entropy analysis of SoM annotations, accompanied by representative examples that highlight the complexities of interpreting and working with metabolism data. Furthermore, we demonstrate the impact and value of the new metabolism data on SoM prediction. Importantly, a substantial portion of the data generated and analyzed as part of this work is made publicly available.

Molecular PharmaceuticsVol. 22(11)
University of Vienna (AT), University of Milan (IT), AstraZeneca (Australia) (AU), AstraZeneca (Sweden) (SE), AstraZeneca (United States) (US), BOKU University (AT)
Openalex Percentile: Top 12%
Computational Drug Discovery Methods
1.50
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.